HPV vaccine impact in australian women: Ready for an HPV-based screening program

Medical Journal of Australia

Volumn 204, Issue 5, 2016, Pages 184-184.e1

  Brotherton, Julia Ml ^b   Gertig, Dorota M ^a,b   May, Cathryn ^a   Chappell, Genevieve ^a   Saville, Marion ^a,b  

^a VICTORIAN CYTOLOGY SERVICE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

AUSTRALIA; FEMALE; HEALTH PROGRAM; HIGH RISK PATIENT; HUMAN; NOTE; SCREENING; UTERINE CERVIX CANCER; VACCINATION; ADOLESCENT; ADULT; CHILD; CROSS-SECTIONAL STUDY; HUMAN PAPILLOMAVIRUS DNA TEST; MASS SCREENING; PRECANCEROUS CONDITIONS; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS; VAGINA SMEAR; VICTORIA; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; HUMAN PAPILLOMAVIRUS DNA TESTS; HUMAN PAPILLOMAVIRUS RECOMBINANT VACCINE QUADRIVALENT, TYPES 6, 11, 16, 18; HUMANS; MASS SCREENING; PRECANCEROUS CONDITIONS; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; VICTORIA; YOUNG ADULT;

EID: 84962596082     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/mja15.01038     Document Type: Note

References (6)

1. Osborne S, Tabrizi SN, Brotherton JML, et al. Assessing human papillomavirus genotype prevalence in young Australian women following the introduction of a national vaccination program. Vaccine 2015; 33: 201-208.
2. Tabrizi SN, Brotherton JM, Kaldor JM, et al. Assessment of herd immunity and cross-protection following a human papillomavirus vaccination programme: a repeat crosssectional study. Lancet Infect Dis 2014; 14: 958-966.
3. Brotherton JML, Malloy M, Budd AC, et al. Effectiveness of less than three doses of quadrivalent human papillomavirus vaccine against cervical intraepithelial neoplasia when administered using a standard dose spacing schedule: observational cohort of young women in Australia. Papillomavirus Res 2015; 1: 59-73.
4. Mullins R, Coomber K, Broun K, Wakefield M. Pro motingcervical screening after introduction of the human papillomavirus vaccine: the effect of repeated mass media campaigns. J Med Screen 2013; 20: 27-32.
5. Casey GM, Morris B, Burnell M, et al. Celebrities and screening: a measurable impact on high-grade cervical neoplasia diagnosis from the “Jade Goody effect” in the UK. Br J Cancer 2013; 109: 1192-1197.
6. Medical Services Advisory Committee. National Cervical Screening Program renewal: effectiveness modelling and economic evaluation in the Australian setting (MSAC application no. 1276.) Canberra: Commonwealth of Australia, 2013. http://www.cancerscreening.gov.au/internet/screening/publishing.nsf/Content/E6A211A6FFC29E2CCA257CED007FB678/$File/Renewal%20Economic%20Evaluation.pdf (accessed Dec 2015)